Read here the profile article on Tuhina Neogi as it appeared in the September issue of The Rheumatologist

Tuhina Neogi, MD, PhD, Now Alan S. Cohen Professor of Rheumatology at Boston University

By Gretchen Henkel

During a virtual award ceremony in February, Tuhina Neogi, MD, PhD, chief of rheumatology and professor of medicine and epidemiology at Boston University School of Medicine, was celebrated as she was named the Alan S. Cohen Professor of Rheumatology. Dr. Neogi has built a strong national and international reputation as a researcher in osteoarthritis (OA) as well as gout, with over 250 publications to date. She is currently conducting a large, longitudinal study of pain sensitization in those with knee OA, and a large-scale evaluation of crystal deposition in knee OA using dual-energy computed tomography.

Serendipity often plays a role in research breakthroughs, she said when accepting the award. But when “pulling back the curtain” to reveal the components of success, she noted, it’s clear that mentors, leaders and strong collaborations pave the way for scientific advancements. Viewing her prodigious output of journal articles, multiple awards and collegial partnerships with mentors as well as mentees, it’s also clear that purposeful work and intelligence have met with serendipity throughout her education and career.

Foundations of Success

Science was an early interest for Dr. Neogi, and at her public high school in Toronto, she found herself surrounded by peers who were academically oriented and who supported and encouraged each other. “Back when I didn’t know what peer networking was, I already had a successful peer network,” she reflects. Through her friends, she learned about a program that matched high school students with scientists at the University of Toronto.

Accepted into the program, Dr. Neogi spent time each week in the research laboratory of neuroscientist Arthur Roach, PhD, who is now director of research at Parkinson’s UK. During her second year of university undergraduate work, she worked with biochemist Charles Deber, PhD, at the Hospital for Sick Children (also known as SickKids). It was “really exciting,” she says, to participate in research he was doing in cystic fibrosis, recalling her first positive “hit” in a site-directed mutagenesis experiment of the CFTR gene.

In addition to her excitement about laboratory research, clinical medicine beckoned, and she went on to obtain her MD from the University of Toronto in 1998. Her first exposure to clinical research in medical school was with Amit Oza, MD, then an oncologist at the Princess Margaret Hospital, and now head of the Division of Medical Oncology and Hematology at the Ontario Institute for Cancer Research, Toronto.

Later, as a rheumatology fellow, Dr. Neogi worked with pediatric rheumatologist and physician scientist Rae Yeung, MD, PhD, who mentored her through her first presentation when her abstract was accepted at an ACR annual meeting. Before her presentation at the meeting, she recalled, Dr. Yeung accompanied her to the podium, showed her how to advance the slides and—even more importantly—how to lower the microphone to her height. (That was an emblematic moment that Dr. Neogi has carried through, she says, whenever she is mentoring other women.)

Dr. Neogi says that what she most appreciated about all of these early mentors was the fact that they took the time to both teach and encourage her in her pursuits. “Those experiences were very positive,” she says, “I don’t know whether, without them, I would have continued trying to pursue research in my career.”

Direction Change

From left: Monica Crespo-Bosque, MD (now faculty at BUSM); MaryAnn Zhang, MD (now faculty at Columbia University); Dr. Neogi; and Ana Vargas Dos Santos, MD, PhD (now faculty at Universidade Estado do Rio de Janeiro, Brazil).

Dr. Neogi’s primary research interest during her rheumatology fellowship was vasculitis, and she fully intended to pursue that path as a basic scientist. However, she encountered another pivotal opportunity: in 2002 she applied for her first grant, a research fellowship award sponsored by the Arthritis Foundation that allowed her to travel to Boston University (BU) for clinical research training.

Interestingly, her first collaboration with David T. Felson, MD, MPH, chief of the clinical epidemiology research and training unit, was his assistance in helping her write that grant that allowed her to obtain training under his mentorship. With the support of the University of Toronto, Dr. Neogi relocated to Boston University, and thrived in the environment of apprenticeship and teamwork fostered by Dr. Felson. She quickly decided, with his encouragement and that of Yuqing Zhang, PhD, to acquire a PhD in epidemiology. Her work advanced from this point, as she began to hone in on research in OA and gout.

In the years since her fellowship, she has had continuous peer-reviewed funding. Her first study on pain in OA was published in BMJ and recognized by the Osteoarthritis Research Society International (OARSI) at its 2009 annual meeting as the leading clinical research paper of the year.1 Multiple awards have followed, including a 2011 OARSI Young Investigator Award and the ACR Henry Kunkel Young Investigator Award in 2014.

Dr. Neogi has been deeply involved with international and regulatory organizations, serving as past chair of the FDA Arthritis Advisory Committee; on the boards of OARSI and the Gout, Hyperuricemia and Crystal-Associated Diseases Network (G-CAN); and on committees for the ACR and the International Association for the Study of Pain (IASP). She has also led ACR treatment guideline development for gout and OA.

Collaborations Abound

Dr. Neogi extolled the teamwork of her section of rheumatology—“we’re like an orchestra, a well-oiled machine,” she says—and praised the unified work ethic they share. “There’s no one single person that outranks everyone else—everyone rolls up their sleeves to get the work done for the success of the whole group.” Dr. Neogi became chief of that section in 2019.

Dr. Neogi has continually expanded collaborations outside of her immediate BU community. For example, she credits Bob Terkeltaub, MD, at the University of California, San Diego, for launching her into gout research. He recommended that she write a gout review for The New England Journal of Medicine, which opened another opportunity for her.2 Now many of her gout and crystal arthritis collaborators are in New Zealand and Europe. Dr. Neogi extended her research in pain sensitization to hand OA through collaboration with Ida Haugen, MD, and her research group in Norway.

Many of her recent collaborations have been with her now-former mentees, including Joshua Stefanik, PT, PhD, Daniel White, PT, PhD, and others. From 2014–19, Dr. Neogi was facilitator and steering committee member for the Mentor Training Program, involved with the development of the training program and facilitating sessions. She has now provided mentorship in musculoskeletal disease-related research for 31 trainees/junior faculty, and has mentored 18 awarded career development grants. She was recognized for her mentoring with the 2016 Robert Dawson Evans Research Mentoring Award, and has received a NIH grant focused on mentoring.

Representation Matters

Dr. Neogi recalled that during her time at the University of Toronto, there were many positive female role models. “It never occurred to me that I wouldn’t be able to do this [work] because all around me I saw women in leadership positions—as the dean of medicine, chair of medicine, or program director—being successful in research, and being nationally and internationally recognized for their work.”

But when she moved to Boston University from Toronto, Dr. Neogi was the only female and sole person of color in the division faculty. Five additional female faculty members are now in the section of rheumatology. There are many programs at the institutional level to increase support of women and faculty from backgrounds underrepresented in medicine, such as the Women’s Leadership Program, a Mid-Career Leadership Program, and an Underrepresented Group (URG) Leadership Program. As New England’s largest safety net hospital, the institution prides itself on serving the underserved. Dr. Neogi serves on the Diversity and Inclusion Advisory Council on the medical campus.

“We have explicit conversations about diversity and equity and how we can best serve our patients,” she says.

In fellowship interviewing, “we’re making strides on how to make our decisions in a less biased manner,” she adds. Applicants are interviewed by at least four different people, including the program director, and standardized questions are used. And, if applicants are identified as being from a background underrepresented in medicine, the faculty selection committee “takes another look,” because research has demonstrated that first impressions are made within 30 seconds and often align with one’s personal similarities.

Keep Options Open

Dr. Neogi is a leader in clinical OA and gout research. Her work has contributed immensely to the understanding of pain and pain mechanisms in OA, the role of bone in OA, as well as exploration of potential therapeutic options such as bisphosphonates and vitamin K; in gout, she has contributed to understanding of potential flare triggers, development of classification criteria, and treatment guidelines.

When asked for her advice to younger rheumatology researchers, she says, “Everyone’s path is different, and I did not have a clear-eyed path to where I am now.” After all, as a rheumatology fellow, she thought she would be a basic scientist and would be specializing in vasculitis. “And so when you see where I am now, a clinical researcher focusing on osteoarthritis and gout, it’s like almost the polar opposite. While we all may have interests when we’re early in our training, you never know where your opportunities and interests may take you. And I think that’s one of the challenges—many people have interests and a focus early on and want to be true to that interest and focus. But that means that they may miss out on opportunities that don’t directly align with that initial interest. So I think it’s important to keep an open mind for where opportunities may lie and new paths may emerge.”

References

  1. Neogi T, Felson D, Niu J, et al. Association between radiographic features of knee osteoarthritis and pain: Results from two cohort studies. BMJ. 2009 Aug 21;339:b2844.
  2. Neogi T. Clinical practice. Gout. N Engl J Med. 2011 Feb 3;364(5):443–452.